Podorol'skaia L V, Andreenko G V, Poliantseva L R, Bumblite I D
Vopr Med Khim. 1996 Oct-Dec;42(4):322-7.
Functional activities of plasminogen activators (FPAA) and their inhibitors and plasminogen activators's (PA), antigen level were determined in 31 patients with chronic glomerulonephritis, 23 patients with amyloidosis and 15 healthy persons. High FPAA correlated with favourable prognosis of diseases, elevated PA antigen level and diminished alpha 1-antitrypsin, alpha 2-macroglobulin and antiactivator activities. There were decreased PA antigen level and increased inhibitor's activities in group with zero FPAA. Protein loaded functional probe demonstrated the presence of PA reserves in high FPAA patients and "pathological proteolysis" in zero FPAA patients. The last phenomenon was likely connected to nonspecific proteases differed from PA.
测定了31例慢性肾小球肾炎患者、23例淀粉样变性患者和15名健康人的纤溶酶原激活剂功能活性(FPAA)及其抑制剂以及纤溶酶原激活剂(PA)的抗原水平。高FPAA与疾病的良好预后、PA抗原水平升高以及α1 -抗胰蛋白酶、α2 -巨球蛋白和抗激活剂活性降低相关。在FPAA为零的组中,PA抗原水平降低且抑制剂活性增加。蛋白质负载功能探针显示高FPAA患者存在PA储备,而FPAA为零的患者存在“病理性蛋白水解”。后一种现象可能与不同于PA的非特异性蛋白酶有关。